Compare VERA & GRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VERA | GRC |
|---|---|---|
| Founded | 2016 | 1933 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2021 | N/A |
| Metric | VERA | GRC |
|---|---|---|
| Price | $50.27 | $50.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $67.67 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 91.0K |
| Earning Date | 11-05-2025 | 10-24-2025 |
| Dividend Yield | N/A | ★ 1.53% |
| EPS Growth | N/A | ★ 31.51 |
| EPS | N/A | ★ 1.91 |
| Revenue | N/A | ★ $678,522,000.00 |
| Revenue This Year | N/A | $4.94 |
| Revenue Next Year | N/A | $4.02 |
| P/E Ratio | ★ N/A | $25.93 |
| Revenue Growth | N/A | ★ 3.19 |
| 52 Week Low | $18.53 | $30.87 |
| 52 Week High | $50.16 | $49.90 |
| Indicator | VERA | GRC |
|---|---|---|
| Relative Strength Index (RSI) | 83.77 | 75.54 |
| Support Level | $40.38 | $48.72 |
| Resistance Level | $47.10 | $46.94 |
| Average True Range (ATR) | 3.45 | 1.20 |
| MACD | 1.32 | 0.50 |
| Stochastic Oscillator | 95.46 | 77.11 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.